Norman, OK, United States of America

Keiko Tsutsumi

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2010.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiko Tsutsumi: Innovator in Gastrointestinal Drug Delivery Systems

Introduction

Keiko Tsutsumi is a prominent inventor based in Norman, OK (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of drug delivery systems. Her innovative work focuses on enhancing the efficacy and efficiency of drug administration in the gastrointestinal tract.

Latest Patents

Keiko Tsutsumi holds a patent for a gastrointestinal-specific multiple drug release system. This invention provides compositions and methods for the multiple release of a drug in the gastrointestinal tract of a subject. The system allows for site-specific release of the drug to both the small intestine and the colon, delivering multiple controlled doses for long-lasting efficacy. This innovation aims to reduce the frequency of drug dosing, improving patient compliance and therapeutic outcomes.

Career Highlights

Keiko is currently associated with Astellas Pharma Inc., where she continues to advance her research in drug delivery technologies. Her work has been instrumental in developing solutions that address the challenges of gastrointestinal drug absorption and release.

Collaborations

Keiko collaborates with various professionals in her field, including her coworker James S. Chu. Together, they work on innovative projects that aim to improve drug delivery systems and patient care.

Conclusion

Keiko Tsutsumi's contributions to the field of pharmaceutical sciences, particularly in gastrointestinal drug delivery systems, highlight her role as an influential inventor. Her innovative patent demonstrates her commitment to improving patient outcomes through advanced drug delivery technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…